Dr Carlos Fernández-Díaz on abatacept in RA ILD

from The Rheumatology Podcast · host Oxford University Press

Dr Richard Conway (Dublin, Ireland) and Dr Elena Nikiphorou (London, UK) interview Dr Carlos Fernández-Díaz (Santander, Spain) about his recent paper, which examines the efficacy of abatacept in interstitial lung disease associated with rheumatoid arthritis. Their discussion includes the study’s key learning points, how this research may influence clinical practice, and future research plans.

Episode metadata supplied by the publisher feed · Published Nov 12, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Dr Carlos Fernández-Díaz on abatacept in RA ILD

0:00 8:17

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Rheumatology Podcast?

This episode is 8 minutes long.

When was this The Rheumatology Podcast episode published?

This episode was published on November 12, 2020.

Can I download this The Rheumatology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!